Glioblastoma Archive - Seite 6 von 24 - IOZK

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers

2018-09-26/in Breast Cancer, Glioblastoma, International Publications, Malignant Melanoma, Newcastle Disease Virus, Pancreatic Cancer /von 2018-09-26 / Cancers (Basel) 2018 Sep;10(10)

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte counts

2018-08-29/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2018-08-29 / CNS Oncol 2018 07;7(3):CNS22

Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial

2018-08-22/in Dendritic Cells, Glioblastoma, International Publications /von 2018-08-22 / Cancer Immunol. Immunother. 2018 Nov;67(11):1777-1788

Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials

2018-08-07/in Dendritic Cells, Glioblastoma, International Publications /von 2018-08-07 / Sci Rep 2018 Aug;8(1):11800

Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo

2018-07-31/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2018-07-31 / Sci Rep 2018 Jul;8(1):11470

High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T depletion

2018-07-27/in Dendritic Cells, Glioblastoma, International Publications /von 2018-07-27 / Cancer Immunol. Immunother. 2018 Oct;67(10):1545-1558

Dendritic cell vaccines for high-grade gliomas

2018-07-26/in Dendritic Cells, Glioblastoma, International Publications /von 2018-07-26 / Ther Clin Risk Manag 2018;14:1299-1313

Recurrent Glioblastoma Treated with Recombinant Poliovirus

2018-06-26/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2018-06-26 / N. Engl. J. Med. 2018 07;379(2):150-161

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

2018-05-29/in Dendritic Cells, Glioblastoma, International Publications /von 2018-05-29 / J Transl Med 2018 May;16(1):142

Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme

2018-05-29/in Dendritic Cells, Glioblastoma, International Publications /von 2018-05-29 / Front Immunol 2018;9:727